← Back to Search

Calcium Channel Blocker

Nifedipine 30MG for Pre-eclampsia

Phase 4
Waitlist Available
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at delivery
Awards & highlights

Study Summary

This trial is testing whether or not Nifedipine can help with preeclampsia when labor is induced.

Eligible Conditions
  • Pre-eclampsia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between enrollment and delivery, assessed up to 18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and between enrollment and delivery, assessed up to 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With the Change in Blood Pressure (Both Systolic and Diastolic) Under the Treatment of NIfedipine 30mg XL Versus Placebo
Secondary outcome measures
Number of Participants Stratified by Route of Delivery
Number of Participants Who Required Acute Antihypertension Treatments Postpartum
Number of Participants With Hypotension of ≥30% Decrease in Blood Pressure From Baseline Following Acute Antihypertensive Therapy
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Nifedipine 30MGActive Control1 Intervention
Oral administration of 30mg Nifedipine XL q24 hours until delivery
Group II: PlaceboPlacebo Group1 Intervention
Matching placebo group q24hrs until delivery

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
826 Previous Clinical Trials
502,575 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
Kara M Rood, MD 2020. "Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04392375.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top